Clinical Trial: Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Brief Summary: To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prevention of oral candidiasis in patients with AIDS or AIDS related complex (ARC) (group III or IV, CDC classification).

Detailed Summary:
Sponsor: Bristol-Myers Squibb

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Bristol-Myers Squibb

Dates:
Date Received: November 2, 1999
Date Started:
Date Completion:
Last Updated: October 1, 2007
Last Verified: October 2007